N-Allyl derivatives of uracil (U), thymine (T) and 6-methyluracil (6-MU) were prepared, and their pharmacological activities (hypnotic activity and anticonvulsant activity against pentylenetetrazol (PTZ)-induced seizures) and interactions with three sedative-hypnotics [pentobarbital (PB), barbital (B) and diazepam (DZ)] were investigated in mice. AO,N3-Diallyluracil (DAU) alone exhibited hypnotic and anticonvulsant activities. None of the other allyl derivatives showed both pharmacological activities. As regards interactions, most of the compounds tested prolonged PBinduced sleep at either 80 or 160 mg/kg, i.p. Further, U, T, and 6-MU (160 mg/kg, i.p.) also prolonged the PB-induced sleeping time. DAU showed a prolonging effect on PB-induced sleep when given by intracerebroventricular (i.c.v.) injection. DAU, AO,N3-diallylthymine (DAT) and N1-monoallyluracil (AO-MAU) significantly prolonged the B-induced sleeping time at a dose of 160 mg/kg, i.p. Further, DAU and DAT (40 mg/kg, i.p.) enhanced DZ-induced motor incoordination. These results indicate that U and related compounds possess central nervous system (CNS)-depressant effects and DAU is the most potent among the N-allyl derivatives tested.
In previous studies,1 -6) we reported that allyl-substituted derivatives of barbiturates and related compounds exhibited various pharmacological activities in mice. N-Monoallylbarbital had more potent hypnotic activity than barbital (B).2) Further, these allyl derivatives showed a potent synergistic effect on sedative hypnotic-induced narcosis. In contrast, N,N'-diallylpentobarbital apparently showed an antagonistic effect on B-induced sleep.") These results indicate that allyl-substituted barbiturates have multiple pharmacological activities.
It has been reported that uracil (U) and related oxypyrimidines exhibit some central depressant properties.7-9) U shows a prolonging effect on hexobarbital-induced sleep and anticonvulsant activity against maximal electroshock seizures:7,8) Krooth et al. have reported that pyrimidine bases increase the spontaneous activity at lower doses and decrease the activity at higher ones.9) On the other hand, there is a report that U dose not affect the duration or frequency of wakefulness, slow wave sleep or paradoxical sleep at any dose in rats.10) Since U and thymine (T) have an oxypyrimidine moiety, like the barbiturate, the structure-activity relationships of both compound groups are of interest. However, there has been no study on the pharmacological activity of N-allyl-substituted derivatives of U, T and 6-methyluracil (6-MU), although syntheses of some N-allyl compounds have been reported. 11 -15) In order to reexamine the above findings and confirm the effect of N-allyl 
Results
Pharmacological Activity Table II summarizes the pharmacological activities of each of the N-allyl-substituted derivatives alone. DAU showed some hypnotic and anticonvulsant activities. The HD50 and PTZ-ED50 of DAU were 433 (406-462) mg/kg, i.p. and 259 (215-312) mg/kg, i.p., respectively. The onset time and duration of loss of righting reflex in the DAU-treated group were 5 + 1 min and 60 + 5 min (N= 7/10), respectively, at a dose of 460 mg/kg, i.p. The PTZ-ED50 for DAU was about 60% of its ED50 value. On the other hand, allyl compounds except for DAU exhibited neither loss of righting reflex nor anticonvulsant activity. The acute toxicity (LD50, mg/kg, i.p.) of DAU, 560 (526-596), was lower than that of DAT, 375 4932 Vol. 35 (1987) (347-406), or N1,N3-diallyl-6-methyluracil (DA-6-MU), 425 (389 464). The LD50 values of the other ally! compounds were larger than 500 or 640 mg/kg, i.p. Table III shows the effects of N-allyl derivatives of U, T and 6-MU on PB-and B-induced sleep. DAU and DAT markedly prolonged the PB-induced sleeping time. The duration of sleeping time prolonged by DAU pretreatment was 14-fold greater than the control. DAU 
Potentiation of PB-, B-or DZ-Induced Depressant Activity

Discussion
The results of the present study indicate that the introduction of two allyl groups onto N1 and N3 of the 2,4-dioxopyrimidine ring resulted in an increase of the depressant effect . NAllyl-substituted derivatives of U seem to exhibit more potent depressant effects on the central nervous system (CNS) than N1-and/or N3-allyl-substituted derivatives of barbituric acid according to our previous data.3) Recently, we have reported that N3-benzyluridine exerted hypnotic activity when given by i.c.v. injectidn, 19) and that N3-allyluridine and N3-allylthymidine enhanced the drug-induced central depressant effect.20) A compound that has two substituent groups at N1 and N3 of the U ring may generally possess a potent central depressant effect. The other N-allyl derivatives of U, T and 6-MU alone did not show loss of righting reflex or anticonvulsant activity. The acute toxicity of DAU was lower than that of DAT or DA-6-MU.
The interaction study of the N-allyl compounds with PB showed that the compounds tested (160 mg/kg, i.p.), except for N3-MAU, significantly prolonged the PB-induced sleeping time. Upon i.c.v. administration, only DAU showed a significant potentiation of PB-induced sleep. This might be due to direct action of DAU on the CNS. The other allyl compounds did not show any significant prolonging effects on PB-induced sleep by i .c.v. injection. However, 
